A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months

August 4, 2020

COPD Management

Airway Clearance Therapy

Scientific Conference

Conclusions

Results from this study demonstrate a reduction in the proportion of patients requiring COPD/chronic bronchitis related readmission within 30 days and 12 months of the Aerobika^® OPEP device therapy initiation compared to an alternative OPEP device.
This further supports the use of the Aerobika^® OPEP device as an add-on to usual care to manage COPD/chronic bronchitis patients post-exacerbation and highlights that not all OPEP devices are the same in terms of 30-day and 12-month readmissions

Recommended Solutions

For drug-free therapy or can be used with a nebulizer

A drug-free and easy to use device that can help open weak airways and to loosen mucus, so it can be coughed out.

Spacer for metered dose and soft-mist inhalers

This AEROCHAMBER PLUS* spacer includes the FLOW-VU* indicator and FLOWSIGNAL* whistle and comes in several sizes.

For use with your metered dose inhaler while on the go